beta2AR agonist 4 (compound A19) is a potent and selective beta2-Adrenoceptor agonist with an EC50 of 3.7 pM. beta2AR agonist 4 suppresses the inflammatory cytokines and leukocytes upregulation and improves lung function in COPD rat model[1].
Molecular Weight:
394.85
Formula:
C19H23ClN2O5
Target:
Adrenergic Receptor
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
